Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach.

Journal: Cancer management and research
Published Date: Dec 13, 2017

Abstract

PURPOSE: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been considered a promising treatment option for advanced or recurrent ovarian cancer, but there is no clear evidence based on randomized controlled trials to advocate this approach as a standard therapy. In this study, we aim to present the early outcomes and insights after an interim analysis of a pioneering clinical trial in Brazil.

Authors

  • Thales Paulo Batista
    Department of Surgery/Oncology, IMIP - Instituto de Medicina Integral Professor Fernando Figueira.
  • Vandré Cabral G Carneiro
    Department of Surgery/Oncology, IMIP - Instituto de Medicina Integral Professor Fernando Figueira.
  • Rodrigo Tancredi
    Department of Clinical Oncology, IMIP - Instituto de Medicina Integral Professor Fernando Figueira.
  • Ana Ligia Bezerra Teles
    Department of Anaesthesiology, IMIP - Instituto de Medicina Integral Professor Fernando Figueira, Recife.
  • Levon Badiglian-Filho
    Department of Gynecology, AC Camargo Cancer Center, Sao Paulo.
  • Cristiano Souza Leão
    Department of Surgery, IMIP - Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals